Adenosine a2A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Shen, Hai Ying ^a   Canas, Paula M ^b   Garcia Sanz, Patricia ^c   Lan, Jing Quan ^d   Boison, Detlev ^d   Moratalla, Rosario ^c   Cunha, Rodrigo A ^b,e   Chen, Jiang Fan ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d LEGACY RESEARCH   (United States)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADENOSINE A2A RECEPTOR; COCAINE; DYNORPHIN; ENKEPHALIN; PHOSPHOPROTEIN DARPP 32; PROTEIN C FOS; PSYCHOSTIMULANT AGENT; THREONINE; GLUTAMIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FOREBRAIN; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSYCHOMOTOR ACTIVITY; WESTERN BLOTTING; ANIMAL; CORPUS STRIATUM; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; PHOSPHORYLATION; PSYCHOMOTOR PERFORMANCE; SYNAPTOSOME;

ANIMALS; COCAINE; CORPUS STRIATUM; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; GABAERGIC NEURONS; GENE EXPRESSION; GLUTAMIC ACID; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; PSYCHOMOTOR PERFORMANCE; RECEPTOR, ADENOSINE A2A; SYNAPTOSOMES;

EID: 84896732955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080902     Document Type: Article

References (53)

1. Pennartz CM (2009) Identification and integration of sensory modalities: neural basis and relation to consciousness. Conscious Cogn 18: 718-739.
2. Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 15: 285-320.
3. 2A receptors and basal ganglia physiology. Prog Neurobiol 83: 277-292.
4. 2Areceptors in brain: morphological substrates for integration of striatal function. Neurology 61: S12-S18.
5. 2A receptor heteromers. J Neurosci 26: 2080-2087.
6. 2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission. Neuropharmacology 53: 783-789.
7. 2A receptors in cortical neurotransmission to the striatal direct pathway. ScientificWorldJournal 9: 1321-1344.
8. 2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission. J Neurochem 116: 273-280.
9. 2A receptor knock-outs. J Neurosci 28: 2970-2975.
10. 2A receptors in amphetamine sensitization. Neuropsychopharmacology 30: 891-900.
11. 2A adenosine receptors. J Neurosci 22: 1054-1062.
12. 2A receptors contribute to L-3,4-dihydroxyphenylalanine- induced dyskinesia in hemiparkinsonian mice. J Neurosci 26: 13548-13555.
13. Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, et al. (2004) DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44: 269-296. (Pubitemid 38263842)
14. Nishi A, Watanabe Y, Higashi H, Tanaka M, Nairn AC, et al. (2005) Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. Proc Natl Acad Sci U S A 102: 1199-1204. (Pubitemid 40170749)
15. Bateup HS, Svenningsson P, Kuroiwa M, Gong S, Nishi A, et al. (2008) Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat Neurosci 11: 932-939.
16. Bateup HS, Santini E, Shen W, Birnbaum S, Valjent E, et al. (2010) Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc Natl Acad Sci U S A 107: 14845-14850.
17. Bertran-Gonzalez J, Bosch C, Maroteaux M, Matamales M, Herve D, et al. (2008) Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28: 5671-5685.
18. Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, et al. (2000) Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A 97: 1856-1860. (Pubitemid 30118533)
19. Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, et al. (2002) Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 418: 774-778.
20. Nishi A, Bibb JA, Snyder GL, Higashi H, Nairn AC, et al. (2000) Amplification of dopaminergic signaling by a positive feedback loop. Proc Natl Acad Sci U S A 97: 12840-12845.
21. Ferré S, Fredholm BB, Morelli M, Popoli P, Fuxe K (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20: 482-487. (Pubitemid 27421712)
22. 2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J Neurochem 92: 433-441.
23. Hack SP, Christie MJ (2003) Adaptations in adenosine signaling in drug dependence: therapeutic implications. Crit Rev Neurobiol 15: 235-274. (Pubitemid 38931486)
24. Bonci A, Williams JT (1996) A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16: 631-639. (Pubitemid 26101113)
25. Fiorillo CD, Williams JT (2000) Selective inhibition by adenosine of mGluR IPSPs in dopamine neurons after cocaine treatment. J Neurophysiol 83: 1307-1314. (Pubitemid 30159559)
26. Harvey J, Lacey MG (1997) A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J Neurosci 17: 5271-5280.
27. Manzoni O, Pujalte D, Williams J, Bockaert J (1998) Decreased presynaptic sensitivity to adenosine after cocaine withdrawal. J Neurosci 18: 7996-8002. (Pubitemid 28441037)
28. Manzoni OJ, Manabe T, Nicoll RA (1994) Release of adenosine by activation of NMDA receptors in the hippocampus. Science 265: 2098-2101. (Pubitemid 24325694)
29. 2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience 84: 223-228.
30. 2A adenosine receptors in the striatum selectively impairs habit formation. J Neurosci 29: 15100-15103.
31. Hikida T, Kimura K, Wada N, Funabiki K, Nakanishi S (2010) Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 66: 896-907.
32. Durieux PF, Schiffmann SN, de Kerchove d'Exaerde A (2012) Differential regulation of motor control and response to dopaminergic drugs by D1R and D2R neurons in distinct dorsal striatum subregions. EMBO J 31: 640-653.
33. Kravitz AV, Freeze BS, Parker PR, Kay K, Thwin MT, et al. (2010) Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466: 622-626.
34. Lobo MK, Covington HE, 3rd, Chaudhury D, Friedman AK, Sun H, et al. (2010) Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330: 385-390.
35. Taverna S, Ilijic E, Surmeier DJ (2008) Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J Neurosci 28: 5504-5512.
36. Yin HH, Lovinger DM (2006) Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc Natl Acad Sci U S A 103: 8251-8256. (Pubitemid 43801084)
37. Morelli M, Fenu S, Pinna A, Di Chiara G (1994) Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 251: 21-25.
38. Pollack AE, Fink JS (1996) Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats. Brain Res 743: 124-130. (Pubitemid 27028765)
39. Pollack AE, Fink JS (1995) Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway. Neuroscience 68: 721-728.
40. Lindskog M, Svenningsson P, Fredholm BB, Greengard P, Fisone G (1999) Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Neuroscience 88: 1005-1008. (Pubitemid 28546983)
41. Sebastião AM, Ribeiro JA (2000) Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 21: 341-346.
42. 1 receptors. J Neurosci 18: 1987-1995.
43. 2A receptor antagonists. PLoS One 6: e16088.
44. 2A receptors in psychiatric disorders. Curr Pharm Des 14: 1512-1524.
45. Price M, Lemaistre M, Pischetola M, Di Lauro R, Duboule D (1991) A mouse gene related to Distal-less shows a restricted expression in the developing forebrain. Nature 351: 748-751. (Pubitemid 21896681)
46. Bulfone A, Kim HJ, Puelles L, Porteus MH, Grippo JF, et al. (1993) The mouse Dlx-2 (Tes-1) gene is expressed in spatially restricted domains of the forebrain, face and limbs in midgestation mouse embryos. Mech Dev 40: 129-140. (Pubitemid 23115146)
47. Bulfone A, Puelles L, Porteus MH, Frohman MA, Martin GR, et al. (1993) Spatially restricted expression of Dlx-1, Dlx-2 (Tes-1), Gbx-2, and Wnt- 3 in the embryonic day 12.5 mouse forebrain defines potential transverse and longitudinal segmental boundaries. J Neurosci 13: 3155-3172. (Pubitemid 23199240)
48. 2Areceptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Ann Neurol 63: 338-346.
49. 2A receptors in striatal neurons enhances working memory and reversal learning. Learn Mem 18: 459-474.
50. Rodrigues RJ, Canas PM, Lopes LV, Oliveira CR, Cunha RA (2008) Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats. Neurobiol Aging 29: 1597-1601.
51. Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, et al. (2005) Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J Neurosci 25: 8432-8438. (Pubitemid 41324729)
52. Darmopil S, Martin AB, De Diego IR, Ares S, Moratalla R (2009) Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Biol Psychiatry 66: 603-613.
53. Moratalla R, Elibol B, Vallejo M, Graybiel AM (1996) Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17: 147-156. (Pubitemid 26251599)